Compare NTRA & ULTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTRA | ULTA |
|---|---|---|
| Founded | 2003 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.0B | 23.8B |
| IPO Year | 2015 | 2007 |
| Metric | NTRA | ULTA |
|---|---|---|
| Price | $200.50 | $537.33 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 23 |
| Target Price | $259.07 | ★ $663.95 |
| AVG Volume (30 Days) | ★ 1.2M | 593.2K |
| Earning Date | 05-07-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 0.65 | ★ 1.18 |
| EPS | N/A | ★ 25.64 |
| Revenue | $210,939,000.00 | ★ $12,392,820,000.00 |
| Revenue This Year | $18.08 | $9.31 |
| Revenue Next Year | $19.65 | $5.11 |
| P/E Ratio | ★ N/A | $21.10 |
| Revenue Growth | N/A | ★ 9.71 |
| 52 Week Low | $131.81 | $377.63 |
| 52 Week High | $256.36 | $714.97 |
| Indicator | NTRA | ULTA |
|---|---|---|
| Relative Strength Index (RSI) | 47.95 | 42.26 |
| Support Level | $186.89 | $499.15 |
| Resistance Level | $204.34 | $537.57 |
| Average True Range (ATR) | 9.67 | 15.77 |
| MACD | -0.16 | 3.59 |
| Stochastic Oscillator | 46.72 | 37.20 |
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
Ulta Beauty is the largest specialized beauty retailer in the US with about 1,500 freestanding stores. The firm offers cosmetics (39% of 2024 sales), fragrances (13%), skin care (23%), and hair care products (19%). It also has salon services, including hair, makeup, skin, and brow, that account for about 4% of its revenue and drive traffic. Outside of the US, Ulta acquired premium beauty retailer Space NK and its 83 stores in the UK and Ireland in 2025, is opening franchised stores in Mexico, and has formed a joint venture to expand into the Middle East. In addition, Ulta collects royalties through its Target partnership (set to end in 2026) and credit card revenue. Ulta was founded in 1990 and is based in Bolingbrook, Illinois.